韓建河山(603616.SH):2020年實現扭虧為盈 預盈2000萬元-3000萬元
格隆匯1月18日丨韓建河山(603616.SH)披露2020年度業績預盈公吿,經財務部門初步測算,預計2020年度實現歸屬於上市公司股東的淨利潤與上年同期相比,將實現扭虧為盈,實現歸屬於上市公司股東的淨利潤2000萬元到3000萬元。歸屬於上市公司股東扣除非經常性損益後的淨虧損8500萬元-9500萬元。
公司此次業績預盈主要是出售北京河山鴻運物流有限公司51%股權、出售安徽建淮管業工程有限公司100%股權,在合併財務報表中,對於剩餘股權,公司按照喪失控制權日的公允價值進行重新計量,合計形成投資收益1.1億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.